MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1452.82

Change

-10.58 (-0.72)%

Market Cap

N/A

Volume

0.10M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-0.49 (-0.18%)

USD 197.82B
IQV IQVIA Holdings Inc

+2.44 (+1.07%)

USD 42.80B
A Agilent Technologies Inc

+0.42 (+0.29%)

USD 41.65B
LH Laboratory Corporation of Amer..

+0.93 (+0.43%)

USD 18.06B
DGX Quest Diagnostics Incorporated

-1.34 (-0.88%)

USD 17.19B
QGEN Qiagen NV

+0.03 (+0.07%)

USD 10.05B
CRL Charles River Laboratories

+1.15 (+0.61%)

USD 9.79B
VNRX Volitionrx Ltd

+0.12 (+16.21%)

USD 0.06B
ENZ Enzo Biochem Inc

+0.01 (+0.88%)

USD 0.06B
TMO Thermo Fisher Scientific Inc

-2.31 (-0.38%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

-0.01 (-1.02%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

+0.01 (+-1.02%)

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

N/A

N/A
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.19 % 0.00 %

+0.02 (+-1.02%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.19 % 0.00 %

-0.11 (-1.02%)

N/A
XLVE:CA Mulvihill U.S. Health Car.. 1.82 % 0.00 %

N/A

N/A
HECO 0.00 % 0.95 %

N/A

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

+1.29 (+-1.02%)

USD 7.60B
QRI:CA 0.00 % 1.06 %

N/A

N/A
ZHU:CA BMO Equal Weight US Healt.. 0.00 % 0.00 %

N/A

CAD 0.01B
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
ZUH:CA BMO Equal Weight US Healt.. 0.00 % 0.39 %

+0.31 (+-1.02%)

CAD 0.27B
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
BMED BlackRock Future Health E.. 0.00 % 0.00 %

+0.15 (+-1.02%)

USD 4.21M
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.77% 92% A 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.77% 92% A 74% C
Trailing 12 Months  
Capital Gain 34.31% 100% F 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.31% 100% F 74% C
Trailing 5 Years  
Capital Gain 111.70% 100% F 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 111.70% 100% F 85% B
Average Annual (5 Year Horizon)  
Capital Gain 16.66% N/A N/A 80% B-
Dividend Return 16.66% N/A N/A 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.83% N/A N/A 33% F
Risk Adjusted Return 54.03% N/A N/A 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike